lebrikizumab
Marketedupdated 2mo agoby Lilly USA LLC
Approvedcommunity read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for atopic eczema and eczematoid dermatitis and 5 investigational indications.
all catalysts(3)
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that